Use of imatinib mesylate in CML patients autografted in the pre-imatinib mesylate era: A single center experience.

被引：0
|
作者：
Liesveld, JL [1 ]
Nichols, D [1 ]
Ifthikharuddin, JJ [1 ]
Lancet, JE [1 ]
Abboud, CN [1 ]
机构：
[1] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5471
引用
收藏
页码：473B / 473B
页数：1
相关论文
共 50 条
  • [31] Successful allogeneic BMT for CML in blast crisis with pre and post BMT imatinib mesylate (STI 571)
    Chan, MY
    Tan, AM
    Rajalingam, V
    Lou, J
    Tan, CL
    BONE MARROW TRANSPLANTATION, 2002, 29 : S164 - S164
  • [32] Treatment outcomes for imatinib mesylate and allogeneic stem cell transplantation in patients with CML based on RQ-PCR, and the efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistance.
    Sohn, Sang Kyun
    Cho, Yoon Young
    Ahn, Byung Min
    Chae, Yee Soo
    Kim, Jong Gwang
    Moon, Joon Ho
    BLOOD, 2006, 108 (11) : 273B - 273B
  • [33] Diagnosis and Treatment of Chronic Myeloid Leukemia in the Imatinib Mesylate Era: Report of the Experience at "La Raza" Medical Center in Mexico
    Ayala, Manuel
    Avila, Elsa
    Dominguez, Jacqueline
    Aquino, Xochitl
    Vela, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (02): : 57 - 62
  • [34] Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
    Sanchez-Guijo, Fermin M.
    Duran, Soledad
    Galende, Josefina
    Boque, Concepcion
    Nieto, Jose B.
    Balanzat, Josep
    Gracia, Antonio
    Garcia, Isabel
    Avellaneda-Molina, Carmen
    Moreno, Maria-Victoria
    Luno-Fernandez, Elisa
    Hermosilla, Mar
    Manuel Sanchez-Varela, Jose
    Dios, Ana
    Lopez-Garrido, Pilar
    Giraldo, Pilar
    Bargay, Joan
    Maria Domingo, Jose
    Soler, Alfonso
    Salinas, Ramon
    del Canizo, Maria-Consuelo
    LEUKEMIA RESEARCH, 2011, 35 (09) : 1184 - 1187
  • [35] EFFECT OF IMATINIB MESYLATE ON PLATELET AGGREGATION ABNORMALITIES IN BCR-ABL plus CML PATIENTS
    Mogalluru, S. U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 570 - 570
  • [36] Efficacy of the expanded treatment program with imatinib mesylate in 109 patients with chronic myeloid leukemia (CML)
    Vysotskaya, L.
    Golenkov, A.
    Trifonova, E.
    Chernykh, Y.
    Lutskaya, T.
    Inyutkina, N.
    Chukavina, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [37] PBSC collection following G-CSF mobilisation in CML patients treated with imatinib mesylate
    Perseghin, P
    Gambacorti-Passerini, C
    Tornaghi, L
    Pioltelli, P
    Dassi, M
    Elli, E
    Fumagalli, M
    Pogliani, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S148 - S148
  • [38] Abnormal clones in Philadelphia negative (Ph-) cells in CML patients treated with Imatinib mesylate
    Grimoldi, A. G.
    Radaelli, F.
    Benevento, A.
    Buiatiotis, S.
    Busuito, R.
    Iurlo, A.
    Malgara, R.
    Vener, C.
    Ripamonti, F.
    Sanso, S. Fiori
    CHROMOSOME RESEARCH, 2007, 15 : 189 - 189
  • [39] Elderly patients with Ph plus chronic myelogenous leukemia (CML): results of imatinib mesylate treatment
    Roberto, L
    Massimo, B
    Ida, C
    Chiara, S
    Enrico, M
    Marco, M
    Antonio, C
    Rosa, DC
    Eleonora, R
    Giacoma, MS
    Francesca, B
    Antonio, S
    Franco, M
    Giuliana, A
    Fiammetta, N
    LEUKEMIA RESEARCH, 2005, 29 (03) : 287 - 291
  • [40] Efficacy of imatinib mesylate dose escalation in CML patients showing suboptimal response to standard dose
    Kim, D. Y.
    Kim, H. J.
    Jeong, J. S.
    Kim, S. J.
    Joo, Y. D.
    Sohn, S. K.
    Kim, I.
    Kim, J. S.
    Song, H. S.
    Yoon, S. S.
    Kim, C. S.
    Jung, C. W.
    Yi, K. H.
    Min, Y. H.
    Hyun, M. S.
    Lee, N. R.
    Chang, D. Y.
    Jo, D. Y.
    Kim, J. A.
    Park, J. W.
    Kim, B. K.
    Park, S.
    BLOOD, 2007, 110 (11) : 871A - 871A
12345